:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
On this ground the WHO updated its DR-TB treatment guidelines in 2022 (WHO Consolidated Guidelines on Tuberculosis, 2024), recommending the 6-month BPaL-M regimen for MDR/Rifampicin-Resistant (RR)-TB in patients unexposed to bedaquiline, pretomanid, or linezolid (Johnson et al., 2024)
PLOS ONE 7 , e37386 (2012)
The safety and efficacy of this specific combination have not been directly evaluated by the FDA
The study demonstrated that MOTS-c levels in the blood of centenarians, individuals who have survived to 100 years and older, were significantly higher than in age-matched individuals with shorter lifespans, and resembled levels seen in much younger adults [2]
US$ 27.14
US$ 29.92
US$ 26.86
US$ 27.65
US$ 25.53
US$ 25.69
US$ 22.20
US$ 26.33
US$ 24.22
US$ 25.70
